Clinical Trials Conference 2022

Over the course of the past several years CCC has endeavored and made considerable progress in fostering patient and patient group partnerships among stakeholders who have been advocating for their engagement in the clinical trial continuum with the goal of increasing patient access to cancer clinical trials in Canada.

The theme for our 6th Annual Patient-Centered Approach to Clinical Trials Conference is: Disruption and Innovation in Cancer Care. This seminal pan-cancer conference continues to inform clinical trial networks, researchers, industry, and academic trial sponsors, HTA agencies, Health Canada, and national and international cancer patient groups to mention a few.

Opening Remarks and Introductions

Speakers: Anne Marie Wright, President @ ESI & Barry Stein, President & CEO, CCC

Keynote: Patients Take Center Stage

Speaker: Jan Geissler, CEO of Patvocates

A Five Year Retrospective

Barry Stein, President & CEO, CCC - Dr. Stéphanie Michaud, President and CEO @ BioCanRx - Dr. Winson Cheung, GI Medical Oncologist, Chair and Provincial Director of the Health Services Research Program @ Cancer Control Alberta - Michael Duong, Ph.D, Head of Innovation, Hoffmann-La Roche - Stephen Sundquist, Executive Director, 3CTN

Patients Take Center Stage - Gordon's Story Part 1

Speaker: Gordon Levine, Patient Advocate

Patients Take Center Stage - Gordon's Story Part 2

Speaker: Gordon Levine, Patient Advocate

Pharmaceutical Developments – What’s in Play?

Speaker: Dr. Sonny Kohli, VP, Medical & Regulatory Affairs, Roche Pharma Canada

Academic Developments – Where is the Research Going?

Speakers: Dr. Denis-Claude Roy, hematologist and professor in the Department of Medicine at the Université de Montréal - Dr. John Bell, Ph.D. FRSC, FCAHS Senior Scientist, Center for Innovative Cancer Research, Ottawa Hospital Research Institute Professor, Departments of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa - Dr. Robert Holt, Distinguished Scientist, Genome Sciences Centre, BC Cancer Research Institute Scientific Co-Director, BC Cancer Immunotherapy Program Professor of Medical Genetics, University of British Columbia - Dr. Stéphanie Michaud, President and CEO @ BioCanRx

Beyond the Drug Innovation

Speakers: Dr. Andrea Cercek, Medical Oncologist, specializing in the treatment of GI cancers - Dr. Rebecca Auer, Scientific Director for the Cancer Therapeutics Program at the Ottawa Hospital Research Institute

HTA Landscape: Time to Commit to a Process to Re Evaluate Onco Drugs

Speakers: Dr. Sandeep Sehdev, medical oncologist, Ottawa Hospital Cancer Center - Alexandra Chambers, Manager, National Oncology Policy, Novartis Oncology

CADTH and INESSS and the future of HTA Processes

Speakers: Amanda Allard, Ph.D, Director of Pharmaceutical Reviews, CADTH - Sylvie Bouchard, Director of Drug Evaluation and Technology Assessment for Reimbursement Institut national d'excellence en santé et en services sociaux (INESSS)

Closing Remarks

Speaker: Barry Stein, President & CEO, CCC

Welcome and Highlights from Day 1

Speakers: Barry Stein, President & CEO, Colorectal Cancer Canada - Anne Marie Wright, President @ ESI

Keynote: The Next Disruptor of Clinical Trials Is Not Coming from Silicon Valley

Speaker: Craig Lipset, Managing Partner, Clinical Innovation Partners Co-Chair, Decentralized Trials & Research Alliance Adjunct Assistant Professor, Rutgers University Vice President, Foundation for Sarcoidosis Research Vice Chair, MedStar Health Research Institute

Introduction to the new ClinicalTrials.gov site

Speaker: Christina Robinson, MA, Product Owner, ClinicalTrials.gov Beta, National Library of Medicine

Patients Take Center Stage - Jason's Story Part 1

Speaker: Jason Abramovitch, Patient Advocate

Patients Take Center Stage - Jason's Story Part 2

Speaker: Jason Abramovitch, Patient Advocate

Innovation in Study Designs and Types of Trials

Speakers: Ritu Malhotra, Ph.D, Lead Clinical Scientist, Product Development Oncology Officer, Genentech - Taras Carpiac, Executive Director, Innovation & Process Improvement, Amgen

Innovation in Types of Data and Data Collection

Speakers: Alan J. Forster, Executive Vice President, Chief Innovation and Quality Officer at the Ottawa Hospital - Eric Sutherland, head of the Pan-Canadian Health Data Strategy - Michael Duong, Ph.D, Head of Innovation, Hoffmann-La Roche

AI in Pathology: Current Innovations and Future Visions

Speakers: Cristin Taylor, Director of Clinical Science, PathAI - Dr. David S. Klimstra, Founder and Chief Medical Officer, PaigeAI- Dr. Joe Oakley, Medical Director of Biomarker Development, PaigeAI -Dr. Mike Montalto, Chief Scientific Officer, PathAI